Clinical Trial

Effect of Shotblocker in Reducing Intramuscular Injection Pain in Adult Patients

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 3, 2024 (before its estimated December 30, 2024 completion). Its status may not reflect the trial's current state.
Summary
This randomized, double-blind study aimed to determine the effect of ShotBlocker on IMI pain in adult patients who received diclofenac sodium and metamizole sodium as IMI in the emergency department. The main question(s) it aims to answer are as follows: • \[Is there a difference between the pain score averages between the intervention group and the control group after ShotBlocker? Participants \[Participants in both groups are individuals who applied to the emergency department and received IM injections according to the doctor\'s order.\] If there is a comparison group: Researchers will make a comparison with the control group.
Trial Details
NCT Number NCT06624761
Lead Sponsor Yağmur SÜRMELİ
Collaborators: Toros University
Conditions Patients Above 18 Years
Enrollment 60 participants
Start Date 2024-10-14
Primary Completion 2024-12-30 (estimated)
Study Completion 2025-04-01 (estimated)
Updated on ClinicalTrials.gov 2024-10-03